ICN
Executive Summary
ICN: Acquires over 5%, or 568,000 shares of radiopharmacy firm Syncor International, according to a recent 13D filing with the SEC. ICN says it has acquired the shares "as an investment" and "has no plans to participate in the management and control of Syncor".